Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oncopeptides Major Shareholding Notification 2024

May 17, 2024

3091_iss_2024-05-17_79b3dd9d-0e74-4cdd-bd0d-e7cfb0ee8e3c.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Oncopeptides AB

Holder

HealthCap VIII, L.P.

Instrument

Instrument Ordinary shares
Before the transaction
Shares 3,786,307
Voting rights 3,786,307
Transaction
Reason for major shareholding notification Buy
Date 17/05/2024
Limit for number of shares 10 %
Limit for number of votes 10 %
After the transaction
Quantity
Shares 27,296,255
Directly held voting rights 27,296,255
Indirectly held voting rights 0
Percentage
Directly held shares 12.68494 %
Directly held voting rights 12.90958 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 12.90958 % 27,296,255
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 12.90958 % 27,296,255

Group total holdings

Voting rights 27,296,255 Percentage of voting rights 12.90958

Notes (other relevant informations according to law)

The notifications are based on the number of shares and votes in Oncopeptides AB (publ) after the rights issue which ended on 3 May 2024. After the rights issue, assuming the number of shares amounts to 215,186,246 and the number of votes amounts to 211,441,841, as per data communicated by the Company on 6 May 2024.

Published

17/05/2024 14:42

Contact

Name Fabrice Bernhard Phone +4179 860 69 23 Email [email protected]

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25